ASIP Antibody, HRP conjugated

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Generally, we can ship your orders within 1-3 business days after receiving them. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery timelines.
Synonyms
ASIP antibody; AGTI antibody; AGTIL antibody; ASP antibody; Agouti-signaling protein antibody; ASP antibody; Agouti switch protein antibody
Target Names
Uniprot No.

Target Background

Function
Agouti Signaling Protein (ASIP) plays a regulatory role in melanogenesis. ASIP binds to the Melanocortin 1 Receptor (MC1R), preventing alpha-MSH-induced signaling and blocking cAMP production. This downregulates eumelanogenesis (brown/black pigment) and increases pheomelanin (yellow/red pigment) synthesis. In higher primates, ASIP might affect the quality of hair pigmentation rather than its distribution pattern. ASIP may also participate in the neuroendocrine aspects of melanocortin action. Additionally, it could play a role in regulating lipid metabolism within adipocytes.
Gene References Into Functions
  1. ASIP expression is significantly downregulated in human masticatory mucosa during wound healing. PMID: 28005267
  2. Polymorphisms of ASIP were found to be associated with skin, hair, and eye color in a diverse Brazilian population. Further research is necessary to determine its utility in forensic science. PMID: 25801600
  3. Mutations in the ASIP gene are implicated in the development of facial pigmented lesions. PMID: 25705849
  4. Studies indicate that the ASIP TG/TG diplotype, associated with melanoma risk, is linked to a 5-fold increase in the hazard of death from melanoma. PMID: 25382380
  5. An increased risk of melanoma (odds ratio [OR] 1.27, 95% confidence interval [95% CI] 1.03-1.57) was observed in carriers of the rs4911414 variant, located 120 kb upstream of ASIP. PMID: 22628150
  6. Using a population-based cohort of high-risk melanoma cases, a significant effect of both MC1R red hair color (RHC) variants and an ASIP haplotype was demonstrated, but an association with postulated risk SNPs of TYR and TYRP1 could not be replicated. PMID: 22447455
  7. Research suggests that the ASIP locus is associated with a range of non-melanoma skin cancers. PMID: 21221757
  8. Further analysis of binding and functional data suggests that the ASIP C-terminal loop (a six-amino-acid segment closed by the final disulfide bond) is crucial for high-affinity MC1R binding and inverse agonism. PMID: 20831872
  9. Polymorphism in the agouti signaling protein gene is associated with human pigmentation. PMID: 11833005
  10. Results show that men and women of similar age and BMI exhibit similar agouti signal protein mRNA levels in omental and subcutaneous abdominal adipocytes, but a sexual dimorphism exists in the relationship between its expression and BMI. PMID: 12055320
  11. Results identify five genes that are down-regulated by agouti signaling protein (ASIP), indicating a probable role for ASIP in human melanogenesis. PMID: 12519127
  12. Agouti mRNA levels were significantly elevated in type 2 diabetes. Insulin did not regulate agouti mRNA. Agouti can regulate adipogenesis. Elevated agouti levels in human adipose tissue have functional implications. PMID: 14633851
  13. Our study suggests that the ASIP G>A polymorphism exhibits a dominant effect leading to lighter skin color, and that variation in the ASIP gene may have been one of several factors contributing to pigmentation reductions in certain populations. PMID: 15726415
  14. ASIP polymorphism was not associated with pigmentation, nevi, or melanoma risk. PMID: 15998953
  15. A significant role for exon 17b of ASIP in cancer cells was identified. Alternative splicing isoforms, hASIP-sa, hASIP-sb, exhibited different effects on cell growth and Fas/FasL-mediated apoptosis in BEL-7404 human hepatoma cells. PMID: 16091846
  16. An A/G polymorphism in the 3'-UTR region of the agouti signaling protein contributes to dark pigmentation. PMID: 16704456
  17. Cocaine- and amphetamine-regulated transcript protein is colocalized with ASIP and neuropeptide Y in the human hypothalamus. PMID: 17525122
  18. ASIP and TYR pigmentation variants are associated with cutaneous melanoma and basal cell carcinoma. PMID: 18488027
  19. Two coding variants in TPCN2 are associated with hair color, and a variant at the ASIP locus shows a strong association with skin sensitivity to sun, freckling, and red hair. PMID: 18488028
  20. ASIP polymorphism was found not to be associated with skin malignant melanoma or basal cell carcinoma. PMID: 18637131
  21. Polymorphism of pigmentation genes (OCA2 and ASIP) in some populations of Russia. PMID: 19382693
  22. Single nucleotide polymorphisms in ASIP are associated with basal cell carcinoma. PMID: 19384953

Show More

Hide All

Database Links

HGNC: 745

OMIM: 600201

KEGG: hsa:434

STRING: 9606.ENSP00000364092

UniGene: Hs.659995

Subcellular Location
Secreted.
Tissue Specificity
Expressed in adipose tissue, testis, ovary and heart and at lower levels in liver, kidney and foreskin.

Q&A

What is the mechanism of action for HRP-conjugated antibodies in immunodetection?

HRP (Horseradish Peroxidase) conjugated antibodies function through a dual mechanism where the antibody component provides target specificity while the enzyme generates detectable signals. The HRP enzyme catalyzes the oxidation of substrates in the presence of hydrogen peroxide, resulting in colored precipitates (colorimetric detection), light emission (chemiluminescent detection), or fluorescent products . The conjugation process attaches HRP molecules to antibodies through chemical bonds that maintain both immunological specificity and enzymatic activity, creating a powerful detection tool for various immunoassay applications .

How does the structure of HRP-antibody conjugates influence their functionality?

The spatial arrangement and ratio of HRP to antibody molecules significantly impact conjugate performance. Optimal conjugates maintain the antibody's antigen-binding capacity while maximizing enzymatic activity. Actins (like ASIP) are highly conserved proteins involved in various types of cell motility and are ubiquitously expressed in eukaryotic cells . When conjugating antibodies against such targets with HRP, the chemical modification must preserve the critical epitope-binding regions of the antibody. Research indicates that conjugation efficiency depends on both the method used and the specific antibody characteristics, with newer technologies achieving nearly 100% conversion without compromising functionality .

What applications are most suitable for HRP-conjugated ASIP antibodies?

HRP-conjugated ASIP antibodies are versatile reagents applicable across multiple research techniques:

ApplicationDetection MethodAdvantagesDilution Range
Western BlottingChemiluminescentHigh sensitivity, ability to reprobe1:1000-1:5000
ImmunohistochemistryChromogenic (DAB)Permanent staining, tissue localization1:100-1:500
ELISAColorimetric/ChemiluminescentQuantitative analysis, high throughput1:1000-1:5000
In Situ Proximity LigationHRP-mediated amplificationProtein-protein interaction studies1:500-1:1000

Enhanced conjugation methods have shown that properly prepared conjugates can function effectively at dilutions as high as 1:5000, whereas traditional conjugates may require dilutions as low as 1:25 .

What factors influence the sensitivity of HRP-conjugated antibodies in research applications?

Multiple parameters affect the sensitivity of HRP-conjugated antibodies in experimental settings:

  • Conjugation methodology: The modified periodate method with lyophilization demonstrates significantly higher sensitivity compared to classical conjugation approaches (p < 0.001)

  • Enzyme-to-antibody ratio: Higher ratios generally increase signal intensity but may cause steric hindrance at excessive levels

  • Substrate selection: Chemiluminescent substrates typically offer greater sensitivity than chromogenic alternatives

  • Incubation conditions: Temperature, duration, and buffer composition significantly impact reaction kinetics and signal development

  • Detection instrumentation: Specialized imaging systems can detect low signals that might be missed with standard visualization methods

Research has shown that conjugates prepared using enhanced methods can detect antigens at concentrations as low as 1.5 ng, representing a substantial improvement over traditional conjugation techniques .

How can researchers verify successful HRP-antibody conjugation and functionality?

Verification of successful conjugation involves multiple analytical approaches:

  • UV-visible spectrophotometry: Successful conjugates show characteristic absorption profiles with peaks at both 280 nm (antibody) and 430 nm (HRP). The modified absorption at 430 nm compared to unconjugated HRP confirms chemical modification

  • SDS-PAGE analysis: Conjugation alters electrophoretic mobility patterns, with conjugates showing distinct migration differences compared to unconjugated components

  • Direct ELISA testing: Serial dilution testing to establish working concentration ranges and confirm functional activity

  • Immunohistochemical validation: Testing on known positive controls, such as formalin-fixed paraffin-embedded normal human tissue samples

For ASIP-specific antibodies, validation should include testing on tissues with known expression patterns of agouti signaling protein to confirm specificity after conjugation.

How does lyophilization enhance HRP-antibody conjugation efficiency?

Lyophilization represents a critical step in enhancing conjugation efficiency for HRP-antibody preparations:

The process involves activating HRP with sodium meta-periodate to generate aldehyde groups by oxidation of carbohydrate moieties, followed by freeze-drying the activated HRP before mixing with antibodies . This additional step produces several advantages:

  • Reduces reaction volume without changing reactant quantities, increasing molecular collision frequency

  • Enhances binding capacity by allowing antibodies to conjugate with more HRP molecules

  • Creates poly-HRP characteristics that amplify detection signals

  • Enables storage of activated HRP at 4°C for extended periods

  • Produces conjugates that maintain functionality at significantly higher dilutions (1:5000 vs 1:25)

What are the advantages of modern bioconjugation technologies for preparing HRP-antibody conjugates?

Contemporary bioconjugation approaches offer substantial improvements over traditional methods:

SoluLINK bioconjugation technology utilizes the reaction between aromatic hydrazine and aromatic aldehyde to form stable hydrazone bonds, catalyzed by small quantities of aniline . This chemical approach:

  • Achieves nearly 100% conversion of antibody to conjugate form

  • Functions under mild reaction conditions that preserve protein structure

  • Simplifies downstream purification due to complete conversion

  • Works with any properly purified monoclonal or polyclonal mammalian antibody regardless of IgG subclass

  • Produces conjugates free from both residual antibody and unconjugated HRP

  • Completes the entire process (conjugation and purification) within 5 hours with minimal hands-on time

These advancements are particularly valuable for precious antibodies like those targeting ASIP, as they maximize yield and performance from limited starting material.

How can researchers optimize signal-to-noise ratios in experiments using HRP-conjugated antibodies?

Optimizing signal-to-noise ratios requires systematic approaches to minimize background while maximizing specific signals:

  • Purification optimization: Using specialized Q spin filter membranes to selectively bind conjugates and remove unconjugated components

  • Blocking strategy: Implementing comprehensive blocking steps to minimize non-specific binding

  • Dilution optimization: Establishing precise working dilutions through systematic titration experiments

  • Substrate selection: Choosing appropriate substrates based on detection requirements (chemiluminescent for highest sensitivity)

  • Washing protocols: Developing stringent washing procedures to minimize background without removing specific signals

  • Signal amplification: Employing tyramide signal amplification kits for visualization of low-abundance targets

Research indicates that properly purified conjugates free of unconjugated components provide maximum signal-to-noise ratios in immunoassays, particularly important for detecting low-abundance targets like ASIP in complex biological samples .

What are the most common challenges in using HRP-conjugated antibodies and how can they be addressed?

Researchers frequently encounter several challenges when working with HRP-conjugated antibodies:

ChallengePotential CausesSolutions
Low signal intensityConjugate degradation, insufficient incubation, suboptimal substratePrepare fresh conjugate, increase concentration, optimize incubation conditions, use enhanced chemiluminescent substrate
High backgroundInsufficient blocking, cross-reactivity, excessive conjugate concentrationOptimize blocking protocol, increase washing stringency, titrate conjugate concentration
Non-specific stainingFc receptor binding, endogenous peroxidase activityPre-block with serum, include peroxidase quenching step
Loss of activity during storageImproper storage conditions, microbial contaminationStore at 2-8°C (never freeze), add preservatives, prepare small aliquots

For ASIP antibody detection specifically, background issues may arise in tissues with high endogenous peroxidase activity, requiring careful optimization of quenching procedures.

How can researchers evaluate and validate the performance of custom-conjugated HRP antibodies?

Rigorous validation ensures reliable experimental results:

  • Spectrophotometric analysis: Compare absorption spectra of conjugate with unconjugated components to confirm successful modification

  • Activity testing: Measure enzymatic activity using standardized substrate reactions

  • Dilution response curves: Generate serial dilution experiments to establish sensitivity limits and optimal working concentrations

  • Specificity testing: Compare staining patterns with established controls and alternative detection methods

  • Reproducibility assessment: Perform replicate experiments under identical conditions to ensure consistent performance

  • Cross-reactivity evaluation: Test against related antigens to confirm specificity

  • Stability monitoring: Assess performance over time under various storage conditions

Research demonstrates that properly validated conjugates should maintain consistent performance in replicate assays with minimal variability in signal intensity and background levels .

What recent advances are improving HRP-conjugated antibody performance in research applications?

Several innovations are enhancing the utility of HRP-conjugated antibodies:

  • Recombinant secondary antibodies: Technologies like Superclonal recombinant secondary antibodies provide precise and accurate detection with reduced cross-reactivity

  • F(ab')2 fragments: Use of antibody fragments that maintain strong divalent binding but lack the Fc portion, reducing non-specific interactions

  • SuperBoost tyramide signal amplification: Enhanced signal amplification for fluorescent imaging of low-abundance targets, with SuperBoost EverRed and EverBlue substrates providing permanent colorimetric staining that is also fluorescent

  • All-in-One conjugation kits: Simplified approaches for generating highly purified conjugates from user-supplied antibodies with comprehensive component systems

These developments are particularly valuable for challenging applications like detecting low-abundance signaling proteins such as ASIP in complex tissue environments.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.